,Gcm2

Priyanka Bolel1, Jeremie Oliver Piña2,3, Fabio R Faucz4,5

  • 1Metabolic Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, 20892, United States.

JBMR plus
|September 30, 2025
PubMed
概括

缺少2 (GCM2) 变异的质细胞可以导致甲状腺功能增强症. 这项研究发现,GCM2 p.Y394S 变体在甲状腺侧细胞中增加了 Galectin-3,这是潜在恶性瘤的标志物.